TRENDSPOTTER: Using Musical Copyrights to Protect DNA Sequences May Sound a Sour Note | GenomeWeb

LONDON, May 13 - Genomic companies could be forgiven for asking whether patenting really is the best way to protect their IP. The costs of obtaining a biotech patent are large, the prosecution period is often lengthy--not to say uncertain-and, following grant, the lifetime of a patent may only be a decade or so.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.